Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 328

1.

Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population.

Gilbertson DT, Rothman KJ, Chertow GM, Bradbury BD, Brookhart MA, Liu J, Winkelmayer WC, Stürmer T, Monda KL, Herzog CA, Ashfaq A, Collins AJ, Wetmore JB.

J Am Soc Nephrol. 2019 Feb;30(2):346-353. doi: 10.1681/ASN.2018060581. Epub 2019 Jan 24.

PMID:
30679380
2.

Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Rovin BH, Caster DJ, Cattran DC, Gibson KL, Hogan JJ, Moeller MJ, Roccatello D, Cheung M, Wheeler DC, Winkelmayer WC, Floege J; Conference Participants.

Kidney Int. 2019 Feb;95(2):281-295. doi: 10.1016/j.kint.2018.11.008.

PMID:
30665569
3.

Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Floege J, Barbour SJ, Cattran DC, Hogan JJ, Nachman PH, Tang SCW, Wetzels JFM, Cheung M, Wheeler DC, Winkelmayer WC, Rovin BH; Conference Participants.

Kidney Int. 2019 Feb;95(2):268-280. doi: 10.1016/j.kint.2018.10.018.

PMID:
30665568
4.

Market Consolidation and Mortality in Patients Initiating Hemodialysis.

Erickson KF, Winkelmayer WC, Ho V, Bhattacharya J, Chertow GM.

Value Health. 2019 Jan;22(1):69-76. doi: 10.1016/j.jval.2018.06.008. Epub 2018 Jul 27.

PMID:
30661636
5.

Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD.

Navaneethan SD, Akeroyd JM, Ramsey D, Ahmed ST, Mishra SR, Petersen LA, Muntner P, Ballantyne C, Winkelmayer WC, Ramanathan V, Virani SS.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1842-1850. doi: 10.2215/CJN.03830318. Epub 2018 Nov 29.

PMID:
30498000
6.

Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014).

Awan AA, Niu J, Pan JS, Erickson KF, Mandayam S, Winkelmayer WC, Navaneethan SD, Ramanathan V.

Am J Nephrol. 2018;48(6):472-481. doi: 10.1159/000495081. Epub 2018 Nov 23.

PMID:
30472701
7.

Dialysis Modality and Incident Atrial Fibrillation in Older Patients With ESRD.

Niu J, Shah MK, Perez JJ, Airy M, Navaneethan SD, Turakhia MP, Chang TI, Winkelmayer WC.

Am J Kidney Dis. 2018 Nov 15. pii: S0272-6386(18)31017-5. doi: 10.1053/j.ajkd.2018.09.011. [Epub ahead of print]

PMID:
30449517
8.

External validation of two Framingham cardiovascular risk equations and the Pooled Cohort equations: A nationwide registry analysis.

Wallisch C, Heinze G, Rinner C, Mundigler G, Winkelmayer WC, Dunkler D.

Int J Cardiol. 2018 Nov 5. pii: S0167-5273(18)33145-0. doi: 10.1016/j.ijcard.2018.11.001. [Epub ahead of print]

PMID:
30429082
9.

Did Medicaid Expansion Reduce Mortality Among Patients Initiating Dialysis for Irreversible Kidney Failure?

Erickson KF, Ho V, Winkelmayer WC.

JAMA. 2018 Dec 4;320(21):2206-2208. doi: 10.1001/jama.2018.14291. No abstract available.

PMID:
30422240
10.

Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation.

Hu A, Niu J, Winkelmayer WC.

Semin Nephrol. 2018 Nov;38(6):618-628. doi: 10.1016/j.semnephrol.2018.08.006. Review.

PMID:
30413255
11.

Evaluating the Evidence behind Policy Mandates in US Dialysis Care.

Erickson KF, Winkelmayer WC.

J Am Soc Nephrol. 2018 Dec;29(12):2777-2779. doi: 10.1681/ASN.2018090905. Epub 2018 Nov 2. No abstract available.

PMID:
30389727
12.

Health Insurance in the First 3 Months of Hemodialysis and Early Vascular Access.

Lin E, Mell MW, Winkelmayer WC, Erickson KF.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1866-1875. doi: 10.2215/CJN.06660518. Epub 2018 Nov 1.

PMID:
30385594
13.

Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop.

Tong A, Manns B, Wang AYM, Hemmelgarn B, Wheeler DC, Gill J, Tugwell P, Pecoits-Filho R, Crowe S, Harris T, Van Biesen W, Winkelmayer WC, Levin A, Thompson A, Perkovic V, Ju A, Gutman T, Bernier-Jean A, Viecelli AK, O'Lone E, Shen J, Josephson MA, Cho Y, Johnson DW, Sautenet B, Tonelli M, Craig JC; SONG Implementation Workshop Investigators.

Kidney Int. 2018 Dec;94(6):1053-1068. doi: 10.1016/j.kint.2018.08.018. Epub 2018 Oct 22.

PMID:
30360959
14.

Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis.

Vangala C, Niu J, Lenihan CR, Mitch WE, Navaneethan SD, Winkelmayer WC.

Clin J Am Soc Nephrol. 2018 Oct 8;13(10):1534-1541. doi: 10.2215/CJN.02190218. Epub 2018 Sep 27.

PMID:
30262672
15.

The Relationship between Intradialytic Hypotension and Hospitalized Mesenteric Ischemia: A Case-Control Study.

Seong EY, Zheng Y, Winkelmayer WC, Montez-Rath ME, Chang TI.

Clin J Am Soc Nephrol. 2018 Oct 8;13(10):1517-1525. doi: 10.2215/CJN.13891217. Epub 2018 Sep 20.

PMID:
30237215
16.

Patient-Reported Experiences of Dialysis Care Within a National Pay-for-Performance System.

Brady BM, Zhao B, Niu J, Winkelmayer WC, Milstein A, Chertow GM, Erickson KF.

JAMA Intern Med. 2018 Oct 1;178(10):1358-1367. doi: 10.1001/jamainternmed.2018.3756.

PMID:
30208398
17.

Heterogeneity in Outcomes Among β-Blockers Elucidated by Intradialytic Data.

Vangala C, Winkelmayer WC.

Am J Kidney Dis. 2018 Sep;72(3):318-321. doi: 10.1053/j.ajkd.2018.03.032. No abstract available.

PMID:
30144835
18.

Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease: Atrial Fibrillation.

Winkelmayer WC.

Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1423-1425. doi: 10.2215/CJN.06270518. Epub 2018 Aug 15. No abstract available.

PMID:
30111584
19.

Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis.

O'Shaughnessy MM, Liu S, Montez-Rath ME, Lafayette RA, Winkelmayer WC.

Eur Heart J. 2018 Aug 2. doi: 10.1093/eurheartj/ehy422. [Epub ahead of print]

PMID:
30085056
20.

Association between intensity of statin therapy and mortality in persons with chronic kidney disease.

Walther CP, Richardson PA, Virani SS, Winkelmayer WC, Navaneethan SD.

Nephrol Dial Transplant. 2018 Jul 20. doi: 10.1093/ndt/gfy237. [Epub ahead of print]

PMID:
30053252
21.

Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation.

Airy M, Schold JD, Jolly SE, Arrigain S, Bansal N, Winkelmayer WC, Nally JV Jr, Navaneethan SD.

Am J Nephrol. 2018;48(1):36-45. doi: 10.1159/000491023. Epub 2018 Jul 26.

PMID:
30048961
22.

Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease.

Walther CP, Niu J, Winkelmayer WC, Cheema FH, Nair AP, Morgan JA, Fedson SE, Deswal A, Navaneethan SD.

J Am Heart Assoc. 2018 Jul 6;7(14). pii: e008664. doi: 10.1161/JAHA.118.008664.

23.

Child and Parental Perspectives on Communication and Decision Making in Pediatric CKD: A Focus Group Study.

Gutman T, Hanson CS, Bernays S, Craig JC, Sinha A, Dart A, Eddy AA, Gipson DS, Bockenhauer D, Yap HK, Groothoff J, Zappitelli M, Webb NJA, Alexander SI, Goldstein SL, Furth S, Samuel S, Blydt-Hansen T, Dionne J, Michael M, Wenderfer SE, Winkelmayer WC, Currier H, McTaggart S, Walker A, Ralph AF, Ju A, James LJ, Carter S, Tong A.

Am J Kidney Dis. 2018 Oct;72(4):547-559. doi: 10.1053/j.ajkd.2018.05.005. Epub 2018 Jul 3.

PMID:
29980375
24.

The Role of Big Data in the Development and Evaluation of US Dialysis Care.

Erickson KF, Qureshi S, Winkelmayer WC.

Am J Kidney Dis. 2018 Oct;72(4):560-568. doi: 10.1053/j.ajkd.2018.04.007. Epub 2018 Jun 18.

PMID:
29921451
25.

Cardiovascular Outcomes Reported in Hemodialysis Trials.

O'Lone E, Viecelli AK, Craig JC, Tong A, Sautenet B, Roy D, Herrington WG, Herzog CA, Jafar T, Jardine M, Krane V, Levin A, Malyszko J, Rocco MV, Strippoli G, Tonelli M, Wang AYM, Wanner C, Zannad F, Winkelmayer WC, Webster AC, Wheeler DC.

J Am Coll Cardiol. 2018 Jun 19;71(24):2802-2810. doi: 10.1016/j.jacc.2018.04.012. Review.

PMID:
29903353
26.

Trends in Left Ventricular Assist Device Implantation and Associated Mortality Among Patients With and Without ESRD.

Walther CP, Winkelmayer WC, Deswal A, Niu J, Navaneethan SD.

Am J Kidney Dis. 2018 Oct;72(4):620-622. doi: 10.1053/j.ajkd.2018.03.020. Epub 2018 May 18. No abstract available.

PMID:
29784611
27.

High-density lipoprotein cholesterol and causes of death in chronic kidney disease.

Navaneethan SD, Schold JD, Walther CP, Arrigain S, Jolly SE, Virani SS, Winkelmayer WC, Nally JV Jr.

J Clin Lipidol. 2018 Jul - Aug;12(4):1061-1071.e7. doi: 10.1016/j.jacl.2018.03.085. Epub 2018 Mar 30.

PMID:
29699917
28.

Clinicians' and researchers' perspectives on establishing and implementing core outcomes in haemodialysis: semistructured interview study.

Tong A, Crowe S, Gill JS, Harris T, Hemmelgarn BR, Manns B, Pecoits-Filho R, Tugwell P, van Biesen W, Wang AYM, Wheeler DC, Winkelmayer WC, Gutman T, Ju A, O'Lone E, Sautenet B, Viecelli A, Craig JC.

BMJ Open. 2018 Apr 20;8(4):e021198. doi: 10.1136/bmjopen-2017-021198.

29.

Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Eckardt KU, Bansal N, Coresh J, Evans M, Grams ME, Herzog CA, James MT, Heerspink HJL, Pollock CA, Stevens PE, Tamura MK, Tonelli MA, Wheeler DC, Winkelmayer WC, Cheung M, Hemmelgarn BR; Conference Participants.

Kidney Int. 2018 Jun;93(6):1281-1292. doi: 10.1016/j.kint.2018.02.006. Epub 2018 Apr 12.

30.

De Novo Heart Failure After Kidney Transplantation: Trends in Incidence and Outcomes.

Lenihan CR, Liu S, Deswal A, Montez-Rath ME, Winkelmayer WC.

Am J Kidney Dis. 2018 Aug;72(2):223-233. doi: 10.1053/j.ajkd.2018.01.041. Epub 2018 Mar 29.

PMID:
29605378
31.

Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Turakhia MP, Blankestijn PJ, Carrero JJ, Clase CM, Deo R, Herzog CA, Kasner SE, Passman RS, Pecoits-Filho R, Reinecke H, Shroff GR, Zareba W, Cheung M, Wheeler DC, Winkelmayer WC, Wanner C; Conference Participants .

Eur Heart J. 2018 Jun 21;39(24):2314-2325. doi: 10.1093/eurheartj/ehy060. No abstract available.

32.

Scope and Consistency of Outcomes Reported in Randomized Trials Conducted in Adults Receiving Hemodialysis: A Systematic Review.

Sautenet B, Tong A, Williams G, Hemmelgarn BR, Manns B, Wheeler DC, Tugwell P, van Biesen W, Winkelmayer WC, Crowe S, Harris T, Evangelidis N, Hawley CM, Pollock C, Johnson DW, Polkinghorne KR, Howard K, Gallagher MP, Kerr PG, McDonald SP, Ju A, Craig JC.

Am J Kidney Dis. 2018 Jul;72(1):62-74. doi: 10.1053/j.ajkd.2017.11.010. Epub 2018 Feb 21.

PMID:
29475768
33.

Market Competition and Health Outcomes in Hemodialysis.

Erickson KF, Zheng Y, Ho V, Winkelmayer WC, Bhattacharya J, Chertow GM.

Health Serv Res. 2018 Oct;53(5):3680-3703. doi: 10.1111/1475-6773.12835. Epub 2018 Feb 22.

PMID:
29468675
34.

Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Swanepoel CR, Atta MG, D'Agati VD, Estrella MM, Fogo AB, Naicker S, Post FA, Wearne N, Winkler CA, Cheung M, Wheeler DC, Winkelmayer WC, Wyatt CM; Conference Participants.

Kidney Int. 2018 Mar;93(3):545-559. doi: 10.1016/j.kint.2017.11.007. Epub 2018 Feb 3.

35.

Employment among Patients Starting Dialysis in the United States.

Erickson KF, Zhao B, Ho V, Winkelmayer WC.

Clin J Am Soc Nephrol. 2018 Feb 7;13(2):265-273. doi: 10.2215/CJN.06470617. Epub 2018 Jan 18.

36.

Health Insurance and the Use of Peritoneal Dialysis in the United States.

Perez JJ, Zhao B, Qureshi S, Winkelmayer WC, Erickson KF.

Am J Kidney Dis. 2018 Apr;71(4):479-487. doi: 10.1053/j.ajkd.2017.09.024. Epub 2017 Dec 23.

PMID:
29277511
37.

Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis.

Airy M, Chang TI, Ding VY, Goldstein BA, Bansal N, Niu J, Navaneethan SD, Turakhia MP, Winkelmayer WC.

Nephrol Dial Transplant. 2018 Sep 1;33(9):1590-1597. doi: 10.1093/ndt/gfx301.

PMID:
29145634
38.

Treating Depression in Patients With Advanced CKD: Beyond the Generalizability Frontier.

Walther CP, Shah AA, Winkelmayer WC.

JAMA. 2017 Nov 21;318(19):1873-1874. doi: 10.1001/jama.2017.17553. No abstract available.

PMID:
29101401
39.

Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients.

Brunelli SM, Spiegel DM, Du Mond C, Oestreicher N, Winkelmayer WC, Kovesdy CP.

Nephrol Dial Transplant. 2018 Jul 1;33(7):1207-1214. doi: 10.1093/ndt/gfx241.

40.

Common Elements in Rare Kidney Diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Aymé S, Bockenhauer D, Day S, Devuyst O, Guay-Woodford LM, Ingelfinger JR, Klein JB, Knoers NVAM, Perrone RD, Roberts J, Schaefer F, Torres VE, Cheung M, Wheeler DC, Winkelmayer WC; Conference Participants.

Kidney Int. 2017 Oct;92(4):796-808. doi: 10.1016/j.kint.2017.06.018. Erratum in: Kidney Int. 2017 Dec;92(6):1558.

41.

Patterns of NSAIDs Use and Their Association with Other Analgesic Use in CKD.

Zhan M, St Peter WL, Doerfler RM, Woods CM, Blumenthal JB, Diamantidis CJ, Hsu CY, Lash JP, Lustigova E, Mahone EB, Ojo AO, Slaven A, Strauss L, Taliercio JJ, Winkelmayer WC, Xie D, Fink JC; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1778-1786. doi: 10.2215/CJN.12311216. Epub 2017 Aug 15.

42.

Hospitalizations and Nursing Facility Stays During the Transition from CKD to ESRD on Dialysis: An Observational Study.

Montez-Rath ME, Zheng Y, Tamura MK, Grubbs V, Winkelmayer WC, Chang TI.

J Gen Intern Med. 2017 Nov;32(11):1220-1227. doi: 10.1007/s11606-017-4151-6. Epub 2017 Aug 14.

43.

Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease.

Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Blum MF, Winkelmayer WC, Nally JV Jr.

Kidney Int. 2017 Nov;92(5):1272-1281. doi: 10.1016/j.kint.2017.04.030. Epub 2017 Jul 24.

44.

A Case for More Frequent, Not Just Earlier, Nephrology Care of Patients Approaching ESRD?

Qureshi S, Erickson KF, Winkelmayer WC.

Am J Kidney Dis. 2017 Aug;70(2):155-157. doi: 10.1053/j.ajkd.2017.04.016. No abstract available.

PMID:
28739124
45.

Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies Conference.

Baigent C, Herrington WG, Coresh J, Landray MJ, Levin A, Perkovic V, Pfeffer MA, Rossing P, Walsh M, Wanner C, Wheeler DC, Winkelmayer WC, McMurray JJV; KDIGO Controversies Conference on Challenges in the Conduct of Clinical Trials in Nephrology Conference Participants.

Kidney Int. 2017 Aug;92(2):297-305. doi: 10.1016/j.kint.2017.04.019.

46.

Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study.

Shen JI, Saxena AB, Vangala S, Dhaliwal SK, Winkelmayer WC.

BMC Nephrol. 2017 Jun 17;18(1):196. doi: 10.1186/s12882-017-0616-4.

47.

Associations of Glycemic Control With Cardiovascular Outcomes Among US Hemodialysis Patients With Diabetes Mellitus.

Rhee JJ, Zheng Y, Montez-Rath ME, Chang TI, Winkelmayer WC.

J Am Heart Assoc. 2017 Jun 7;6(6). pii: e005581. doi: 10.1161/JAHA.117.005581.

48.

A comparison of risk prediction methods using repeated observations: an application to electronic health records for hemodialysis.

Goldstein BA, Pomann GM, Winkelmayer WC, Pencina MJ.

Stat Med. 2017 Jul 30;36(17):2750-2763. doi: 10.1002/sim.7308. Epub 2017 May 2.

49.

Statin use and hip fractures in U.S. kidney transplant recipients.

Vangala C, Lenihan CR, Montez-Rath ME, Nair SS, Navaneethan SD, Ramanathan V, Winkelmayer WC.

BMC Nephrol. 2017 May 1;18(1):145. doi: 10.1186/s12882-017-0559-9.

50.

Worldwide Preparedness for Kidney Health Care.

Mandayam S, Winkelmayer WC.

JAMA. 2017 May 9;317(18):1838-1839. doi: 10.1001/jama.2017.2825. No abstract available.

PMID:
28430831

Supplemental Content

Loading ...
Support Center